首页> 外文期刊>Cell biology international. >RAR alpha mediates all-trans-retinoic acid-induced VEGF-C, VEGF-D, and VEGFR3 expression in lung cancer cells
【24h】

RAR alpha mediates all-trans-retinoic acid-induced VEGF-C, VEGF-D, and VEGFR3 expression in lung cancer cells

机译:RAR alpha介导肺癌细胞中全反式维甲酸诱导的VEGF-C,VEGF-D和VEGFR3表达

获取原文
获取原文并翻译 | 示例
           

摘要

The regulation of vascular endothelial growth factors C (VEGF-C) and D (VEGF-D), and their receptor VEGFR3 gene and protein expression by all-trans-retinoic acid (atRA) in A549 lung cancer cells, was investigated. We showed that atRA treatment increased VEGF-C, VEGF-D, and VEGFR3 protein and mRNA contents in dose-dependent manner. atRA-mediated increase of both ligands and receptor expression correlated with the elevated level of retinoic acid receptor (RAR) expression, while the level of another atRA receptor, peroxisome proliferator-activated receptor / (PPAR/), was decreased. We demonstrated that the classical counterpart of RAR, retinoid X receptor (RXR), was down-regulated in both cytoplasm and nucleus of A549 cells upon atRA addition. On the contrary, the nuclear quantity of another possible RAR counterpart, transcription factor Sp1, was increased after atRA treatment.
机译:研究了全反式维甲酸(atRA)对A549肺癌血管内皮生长因子C(VEGF-C)和D(VEGF-D)的调节,以及它们的受体VEGFR3基因和蛋白质表达。我们显示atRA治疗以剂量依赖性方式增加VEGF-C,VEGF-D和VEGFR3蛋白和mRNA含量。 atRA介导的配体和受体表达的增加与视黄酸受体(RAR)表达水平的升高相关,而另一种atRA受体过氧化物酶体增殖物激活的受体/(PPAR /)的水平则降低了。我们证明,添加atRA后,A549细胞的细胞质和细胞核中RAR的经典对应物(类维生素A X受体)都被下调。相反,在atRA治疗后,另一个可能的RAR对应物,转录因子Sp1的核数量增加了。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号